A respiratory therapy system can have a flow generator adapted to provide gases to a patient. A gas passageway can be located in-line with the flow generator. The gas passageway can have a first portion adapted to receive a first gas and a second portion adapted to receive a second gas. The gas passageway can have a static mixer downstream of the first and second portions.

An apparatus (2) for dissolving a gas into a liquid includes a liquid inlet (4) for supplying liquid into the apparatus, a gas inlet (6) for supplying gas into the liquid within the apparatus and a venturi (52) arranged to dissolve the gas into the liquid passing through the venturi. The apparatus also includes an outlet (18) for the liquid and dissolved gas downstream of the venturi. At least part of the liquid inlet, at least part of the gas inlet, at least part of the venturi and at least part of the outlet are formed in an integrally formed piece of material (42).

A continuous ready mix joint or texture compound manufacturing system and a method for continuously manufacturing a ready mix joint or texture compound includes a continuous mixer having an inlet and an outlet, a pump disposed at the outlet of the continuous mixer, and a disperger having an inlet and an outlet. The continuous mixer is adapted to receive at least one dry ingredient and at least one wet ingredient at the inlet and continuously mix the at least one dry ingredient and the at least one wet ingredient to form a mixed composition. The pump is adapted to pump the mixed composition from the outlet of the continuous mixer to the inlet of the disperger. The disperger is adapted to receive the mixed composition and apply a shear force to the mixed composition to form a homogenized, disperged composition.

This invention relates to a process through which intravenous fluids, blood, or artificial blood containing high-levels of mechanically-injected dissolved oxygen can be used to maintain appropriate oxygen levels in the venous blood and thereby provide short-term oxygenation support for compromised or trauma patients. In one aspect, there is provided a system and process for oxygenating a biological fluid for use in a compromised or a trauma subject in need of oxygenation support to maintain appropriate oxygen levels in the subject, the process comprising: supplying oxygen gas from an oxygen source; and dissolving an amount of the supplied oxygen into a biological fluid to obtain an oxygen enriched biological fluid.

A system for introducing gas from an unconventional source into a gas grid pipeline includes a passive blender (10) that introduces gas from an unconventional source (1) into a gas grid (2), the passive blender (10) having gas inputs (3, 11) from the unconventional source (1) and the gas grid (2) and a blended gas output (12), and wherein an internal flow path within the passive blender (10) is shaped and sized to provide entraining and mixing of the gases. The passive blender (10) acts to entrain gas from a gas grid (2) through input (11) by utilising the flow of gas from an unconventional source (1) through input 3, proportionally blending inputs 3 and 11 before outputting the blended gas back to the main gas grid (2). The system comprises the passive blender (10) of the present invention, a first gas input pipe (11) from a grid gas pipeline (2) into the passive blender (10) a second gas input pipe (3) from the unconventional source (1) into the passive blender (1), and an output pipe (12) from the passive blender (10) into the grid gas pipeline (2). The blender (10) and system of the present invention are advantageous in that they can greatly reduce the necessary conditioning of unconventional gas before it is introduced into a gas grid supply (2) without additional means of flow motivation or controls.

A wine aeration device and methods of aerating wine that draw wine from the bottom ⅓ of the container into an aeration chamber where the wine undergoes a first phase of aeration. The wine continues through a return tube into the container where it undergoes a second phase of aeration by way of multiple slits in the return tube causing a venturi effect on the flowing wine.

A chemical liquid preparation method of preparing a chemical liquid for treating a film formed on a substrate, including a gas dissolving process in which an oxygen-containing gas and an inert-gas-containing gas are dissolved in the chemical liquid by supplying the oxygen-containing gas which contains oxygen gas and the inert-gas-containing gas which contains an inert gas to a chemical liquid, wherein in the gas dissolving process, a dissolved oxygen concentration in the chemical liquid is adjusted by setting a mixing ratio between the oxygen-containing gas and the inert-gas-containing gas supplied to the chemical liquid as a mixing ratio corresponding to a predetermined target dissolved oxygen concentration.

Analyzers are described that control sample agitation by detecting vibration acceleration and using feedback to control the agitation and also alert to the presence of abnormal agitation. An embodiment provides an analyzer comprising a liquid agitation unit; an agitated liquid analysis unit; and a unit that controls the agitation unit. The agitation unit includes a vibrator of a liquid container and a detector of vibration of the container and that outputs a signal to the control unit, which responds by regulating the vibrator.

The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics. This invention allows for a process to produce monodispersed particles of varying sizes and may be used to rapidly screen for optimal size for maximal bioavailability of API particles either on lab bench for in vitro dissolution or in vivo studies, and patient-specific handhelds for maximal drug inhalation.

A molded product production system includes at least two measuring feeders configured to simultaneously adjust an amount of a discharged powdery material to a target value and feed the powdery material, a mixer configured to mix at least two powdery materials fed from the measuring feeders to obtain mixed powdery materials, a filler configured to fill, with the mixed powdery materials obtained by the mixer, a die bore of a compression-molding machine configured to compress a powdery material to mold a molded product, a sensor configured to measure a mixing degree of the mixed powdery materials obtained by the mixer, and a controller configured to adjust an amount of at least one of the powdery materials fed by the measuring feeders, or motion speed of a mixing member configured to agitate powdery materials in the mixer in accordance with the mixing degree of the mixed powdery materials measured by the sensor.